Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

October 31, 2012

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

ombrabulin (AVE8062)

"Pharmaceutical form:solution~Route of administration: intravenous"

DRUG

placebo

"Pharmaceutical form:solution~Route of administration: intravenous"

Trial Locations (43)

3022

Investigational Site Number 804003, Kyiv

3550

Investigational Site Number 036002, Bendigo

4215

Investigational Site Number 036001, Southport

10000

Investigational Site Number 191002, Zagreb

Investigational Site Number 191003, Zagreb

11080

Investigational Site Number 688003, Belgrade

16132

Investigational Site Number 380002, Genova

20052

Investigational Site Number 380001, Monza

20132

Investigational Site Number 380003, Milan

21034

Investigational Site Number 250002, Dijon

21204

Investigational Site Number 688001, Kamenitz

22927

Investigational Site Number 276002, Großhansdorf

33076

Investigational Site Number 250005, Bordeaux

34376

Investigational Site Number 276003, Immenhausen

35661

Investigational Site Number 840001, Muscle Shoals

40003

Investigational Site Number 804002, Sumy

44805

Investigational Site Number 250001, Saint-Herblain

48912

Investigational Site Number 840005, Lansing

49102

Investigational Site Number 804001, Dnipropetrovsk

69373

Investigational Site Number 250003, Lyon

71913

Investigational Site Number 840003, Hot Springs

82131

Investigational Site Number 276001, Gauting

92801

Investigational Site Number 840002, Anaheim

95355

Investigational Site Number 840009, Modesto

115478

Investigational Site Number 643002, Moscow

194291

Investigational Site Number 643004, Saint Petersburg

200385

Investigational Site Number 642004, Craiova

400015

Investigational Site Number 642003, Cluj-Napoca

700106

Investigational Site Number 642001, Iași

2363058

Investigational Site Number 152004, Valparaíso

7510032

Investigational Site Number 152002, Santiago

8380456

Investigational Site Number 152003, Santiago

751-0009

Investigational Site Number 152005, Santiago

Unknown

Investigational Site Number 191001, Zagreb

06189

Investigational Site Number 250004, Nice

20-954

Investigational Site Number 616003, Lublin

60-569

Investigational Site Number 616001, Poznan

02-781

Investigational Site Number 616004, Warsaw

04-125

Investigational Site Number 616005, Warsaw

050098

Investigational Site Number 642002, Bucharest

110-744

Investigational Site Number 410003, Seoul

120-752

Investigational Site Number 410002, Seoul

135-710

Investigational Site Number 410001, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY